Research
OriginalInvestigation
ExerciseandVitaminDinFallPreventionAmongOlderWomen
A Randomized Clinical Trial
KirstiUusi-Rasi,PhD;RadhikaPatil,MSc;SaijaKarinkanta,PhD;PekkaKannus,MD,PhD;KariTokola,MSc;
ChristelLamberg-Allardt,PhD;HarriSievänen,DSc
InvitedCommentary
IMPORTANCEWhilevitaminDsupplementationandexercisearerecommendedfor
Supplementalcontentat
preventionoffallsforolderpeople,resultsregardingthese2factorsarecontradictory. jamainternalmedicine.com
OBJECTIVE TodeterminetheeffectivenessoftargetedexercisetrainingandvitaminD
supplementationinreducingfallsandinjuriousfallsamongolderwomen.
DESIGN,SETTING,ANDPARTICIPANTS A2-yearrandomized,double-blind,placebo-controlled
vitaminDandopenexercisetrialconductedbetweenApril2010andMarch2013inTampere,
Finland.Participantswere409home-dwellingwomen70to80yearsold.Themaininclusion
criteriawereatleast1fallduringthepreviousyear,nouseofvitaminDsupplements,andno
contraindicationtoexercise.
INTERVENTIONS Fourstudygroups,includingplacebowithoutexercise,vitaminD(800IU/d)
withoutexercise,placeboandexercise,andvitaminD(800IU/d)andexercise.
MAINOUTCOMESANDMEASURES Theprimaryoutcomewasmonthlyreportedfalls.Injurious
fallsandthenumberoffallersandinjuredfallerswerereportedassecondaryoutcomes.In
addition,bonedensity,physicalfunctioning(musclestrength,balance,andmobility),and
vitaminDmetabolismwereassessed.
RESULTS Intent-to-treatanalysesshowedthatneithervitaminDnorexercisereducedfalls.
Fallratesper100person-yearswere118.2,132.1,120.7,and113.1intheplacebowithout
exercise,vitaminDwithoutexercise,placeboandexercise,andvitaminDandexercisestudy
groups,respectively;however,injuriousfallrateswere13.2,12.9,6.5,and5.0,respectively.
HazardratiosforinjuredfallersweresignificantlyloweramongexerciserswithvitaminD
(0.38;95%CI,0.17-0.83)andwithoutvitaminD(0.47;95%CI,0.23-0.99).VitaminD
maintainedfemoralneckbonemineraldensityandincreasedtibialtrabeculardensityslightly.
However,onlyexerciseimprovedmusclestrengthandbalance.VitaminDdidnotenhance
exerciseeffectsonphysicalfunctioning.
CONCLUSIONSANDRELEVANCE Therateofinjuriousfallsandinjuredfallersmorethanhalved AuthorAffiliations:UKKInstitutefor
HealthPromotionResearch,
withstrengthandbalancetraininginhome-dwellingolderwomen,whileneitherexercisenor
Tampere,Finland(Uusi-Rasi,Patil,
vitaminDaffectedtherateoffalls.Exerciseimprovedphysicalfunctioning.Futureresearchis Karinkanta,Kannus,Tokola,
neededtodeterminetheroleofvitaminDintheenhancementofstrength,balance,and Sievänen);DepartmentofResearch,
mobility. TampereUniversityHospital,
Tampere,Finland(Uusi-Rasi);School
ofMedicine,UniversityofTampere,
TRIALREGISTRATION clinicaltrials.govIdentifier:NCT00986466 Tampere,Finland(Kannus);Division
ofOrthopaedicsandTraumatology,
DepartmentofTrauma,
MusculoskeletalSurgery,and
Rehabilitation,TampereUniversity
Hospital,Tampere,Finland(Kannus);
DepartmentofFoodand
EnvironmentalSciences,University
ofHelsinki,Helsinki,Finland
(Lamberg-Allardt).
CorrespondingAuthor:KirstiUusi-
Rasi,PhD,UKKInstituteforHealth
PromotionResearch,POBox30,
JAMAInternMed.doi:10.1001/jamainternmed.2015.0225 FI-33501Tampere,Finland
PublishedonlineMarch23,2015. (kirsti.uusi-rasi@uta.fi).
(Reprinted) E1
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
Research OriginalInvestigation ExerciseandVitaminDinFallPrevention
F
allsaretheleadingcauseofunintentionalinjuriesand
fracturesinolderadults.Althoughlessthan1in10falls Methods
resultsinafracture,approximately20%offallsleadto
injuryrequiringmedicalattention.1Therefore,fallpreven- TrialDesign
tioniswidelyconsideredthemostessentialelementinin- Thisstudywasa2-year,double-blind,placebo-controlledvi-
juryandfracturepreventionprogramsinelderlypopulations.2,3 taminDandopenexerciseinterventiontrialwith4arms
Thereisstronghigh-qualityevidencefromrandomizedclini- (Figure1).ThetrialwasperformedbetweenApril2010and
caltrialsandsubsequentsystematicreviewsandmeta- March2013.Eligibilitycriteriaandrecruitmentofpartici-
analysesthatregularstrengthandbalancetrainingcanre- pantshavebeendescribedindetailpreviously.12Briefly,home-
ducetheriskoffallingincommunity-dwellingolderadultsby dwellingwomen70to80yearsoldlivinginTampere,Fin-
15%to50%.4,5 land,wereeligibleiftheyhadfallenatleastonceduringthe
VitaminD,inturn,isknowntobevitalforbonemetabo- previous12months,didnotusevitaminDsupplements,and
lismandhealth.Insufficientserum25-hydroxyvitaminD hadnocontraindicationstoexercise.Individualswhopartici-
(25[OH]D)levelsareassociatedwithincreasedbonelossand patedinmoderatetovigorousexercisemorethan2hoursper
riskoffracturesaswellasincreasedfallrates.Furthermore, weekwereexcludedfromthestudy.
ithasbeensuggestedthatthosewithlow25(OH)Dlevels Thestudyprotocolwasapprovedbytheethicscommit-
havelowerphysicalperformanceandgreaterdeclinesin teeoftheTampereUniversityHospital,Tampere,Finland
physicalfunctioning.6,7However,systematicreviewsand (approvalR09090).Thestudyprotocolcanbefoundinthe
meta-analysesofclinicaltrialsexploringtheroleofvitamin trialprotocolinSupplement1.Eachparticipantprovided
Dinreducingfallsandfracturesincommunity-dwelling writteninformedconsentbeforerandomization.Thestudy
olderpeopleandinimprovingphysicalfunctioningare protocol is registered at clinicaltrials.gov (identifier
inconclusive.8-11 NCT00986466).
Theaimofthisstudywastoinvestigatetheseparateand
combinedeffectsofmultimodalexercisetrainingandvita- SettingandParticipants
minDsupplementationinreducingfallsandinjuriousfallsand Intotal,409participantswererandomlyassignedto1of4
fallersaswellastoassesstheireffectsinimprovingboneden- groupsusingacomputer-generatedlistbasedonsimpleran-
sityandphysicalfunctioningamongolderwomenatriskfor domizationwithrandomallocationsequencetoensureequal
falling. groupsizes.Thegroupswere(1)placebowithoutexercise,
Figure1.CONSORTDiagram
9730Invitation letter
1213Health history
questionnaire to those
willing to participate
Initial assessment for
eligibility by inclusion 780Not eligible
criteria
433Medical examination 16Excluded, did not fulfill
inclusion criteria
Baseline assessment 8Withdrew, lost interest
409Randomization
102Vitamin D and 103Placebo and 102Vitamin D without 102Placebo without
exercise exercise exercise exercise
2Lost interest 3Lost interest 4Lost interest 2Lost interest
4Health reasons 9Health reasons 7Health reasons 3Health reasons
1Spouse illness 2Died
2Died
9624-mo Assessment 9124-mo Assessment 8824-mo Assessment 9524-mo Assessment
CONSORTindicatesConsolidated
StandardsofReportingTrials.
E2 JAMAInternalMedicine PublishedonlineMarch23,2015 (Reprinted) jamainternalmedicine.com
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
ExerciseandVitaminDinFallPrevention OriginalInvestigation Research
(2)vitaminD(800IU/d)withoutexercise,(3)placeboandex- thetibiawereassessedwithperipheralquantitativecom-
ercise,and(4)vitaminD(800IU/d)andexercise. putedtomography(XCT3000;Norland/Stratec).16
Participantsreceivedonedailypillcontaining800IU PhysicalfunctioningwasassessedbytheShortPhysical
(20μg)ofvitaminD orplacebofor24months(trialprotocol PerformanceBattery,17whichcomprisedstaticbalance,4-m
3
inSupplement1).12AlltabletswereprovidedbyOyVerman normalwalkingspeed,and5-timechairstandtestsandbythe
Ab(Kerava,Finland)andweresimilarinsize,appearance, TimedUpandGo(TUG)test.18Dynamicbalancewasas-
andtaste.Eachparticipantreceivedapackofpillsfor6 sessedusingbackwardwalking.19Maximalisometriclegex-
monthsatatime.Usedpackswerereturnedatthetimeof tensorstrengthatakneeangleof110°wasmeasuredbyastrain
laboratorymeasurementsevery6months,andnewfull gaugedynamometer(custommade;Tamtron).Eachpartici-
packsweregiven.Thecompliancewasconfirmedbypill pantrecordedherdailystepswithapedometer(HJ-112-E;Om-
counts. ron)overtheentire24-monthstudyperiod.Alltestsareregu-
Exerciseconsistedofsupervised,progressivegrouptrain- larlyusedinourlaboratoryandhavegoodreproducibility.
ingclasses2timesaweekforthefirst12monthsandoncea
weekfortheremaining12monthsofthe24-monthinterven- Analysisof25(OH)DandParathyroidHormoneLevels
tion(trialprotocolinSupplement1).12Trainingperiodsalter- Fastingserum25(OH)Dlevelwasmeasuredasamarkerofvi-
natingbetweenexercisehallandgymclasseswereledbyphys- taminDmetabolismwithanimmunoenzymometricassay
iotherapists(R.P.andS.K.),whoalsomonitoredattendance. (Octeia;IDS).Reproducibilitywasensuredbyadheringtothe
Exercisehallclassesfocusedonbalancechallenging,weight VitaminDExternalQualityAssessmentScheme(DEQAS;http:
bearing,strengthening,agility,andfunctionalexercises.Gym //deqas.kpmd.co.uk).ThelaboratoryreceivedtheDEQASpro-
classesincludedacombinationofpin-loadedweightma- ficiencycertificatein2012.Interassayvariationwasavoided
chines,pulleys,andfreeweights,beginningwith30%to60% bymeasuringallsamplesfromthesameindividualsinthesame
ofonerepetitionmaximumandprogressingtoatargetlevel series.Serumintactparathyroidhormonewasmeasuredwith
of60%to75%ofonerepetitionmaximum.Exerciseintensity anautomatedimmunoassay(Immuliate1000;SiemensHealth-
wasestimatedinmetabolicequivalenttasks(METs)every8 careDiagnostics).
weeks(version3.0.1.0;FirstbeatTechnologies).Theexercis-
ersalsohadahome-trainingprogram(5-15minutes),modi- RandomizationandBlinding
fiedfromthesupervisedexercises,tobeperformedonallrest Theparticipantswereenrolledbythecorrespondingauthor.
days.Thenonexercisinggroupswereaskedtomaintaintheir Thestudystatistician(K.T.)generatedtheparticipantlist
prestudylevelofphysicalactivity. usingvalidatedrandomizationsoftware.Hewasblindedto
thestudyparticipantsandtheircharacteristicsandran-
OutcomeMeasures domlyallocatedtheminto4groups(simplerandomization).
Theprimaryoutcomewasmonthlyreportedfalls.Secondary Theparticipantsandstudypersonnelwereblindedtothe
outcomesincludedinjuriousfalls,thenumberoffallersand vitaminDtreatmentgroupassignments.Therandomization
injuredfallers,bonedensity,andphysicalfunctioning(muscle codeswereopenedafterthedatacollectionwascompleted
strength,balance,andmobility). andchecked.
Thenumberoffallswasobtainedfromprospectivefalldia-
riesreturnedmonthlyviamail,anddetailsofeachregistered StatisticalAnalysis
fallwereascertainedbyatelephonecall.Afallwasdefinedas Powercalculationsindicatedthatasamplesizeof260(130
“anunexpectedeventinwhichtheparticipantcomestorest exercisersand130nonexercisers)wouldhavean80%power
ontheground,floororlowerlevel.”13(p1619)Injuriousfallswere todetecta30%between-groupdifferenceintherateoffalls
thoseforwhichparticipantssoughtmedicalcare(nurse,phy- duringthe2-yearinterventionwithasignificancelevelof
sician,orhospital)andincludedinjuriessuchasbruises,abra- α=.05.However,toeliminatetheroleofchanceindetect-
sions,contusions,sprains,fractures,andheadinjuries.Less ingthepossibleinteractionofvitaminDandexercise,400
injuriousfallsforwhichmedicaltreatmentwasnotsoughtwere participants(100ineachgroup)wererecruitedintothe
notincludedintheanalysis. study.
Alldatawereanalyzedonanintent-to-treatbasis.Fol-
DataCollection low-uptimesforfalls,fallersandinjuriousfalls,andinjured
Allmeasurementswereobtainedatbaseline,12months,and fallerswerecalculatedfromthebeginningtotheendofthe
24months.Bloodsamplesandphysicalfunctioningwerealso 24-monthinterventionunlesstheparticipantwithdrewfrom
assessedat6monthsand18months.Assessorswereblinded thestudyordied.PairwisemultiplecomparisonswithSidak
togroupassignments. adjustmentwerefirstusedtotestthedifferencesamongtreat-
Bodyheightandweightweremeasuredwithstandard mentgroupsandinteractionbetweenvitaminDandexer-
methods.DietaryintakeofcalciumandvitaminDwasas- cise.Sidakadjustmentenablesthesimultaneouspairwisecom-
sessedwithavalidatedfoodfrequencyquestionnaire.14 parisonofmultiplegroups.
Bodycompositionandarealbonemineraldensity(BMD) Fallincidencerateswerecalculatedasthetotalnumber
ofthelumbarspineandleftproximalfemurwereassessedusing offallsdividedbythetimeoverwhichfallsweremonitored
dual-energyx-rayabsorptiometry(LunarProdigyAdvance;GE (100person-years)ineachgroup.Negativebinomialregres-
Healthcare).15Distalsite(5%)andthemid-diaphysis(50%)of sionwasusedtoestimatetheincidencerateratiosforfallsand
jamainternalmedicine.com (Reprinted) JAMAInternalMedicine PublishedonlineMarch23,2015 E3
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
Research OriginalInvestigation ExerciseandVitaminDinFallPrevention
Table1.BaselineCharacteristicsoftheStudyGroupsa
Placebo VitaminD Placebo VitaminD
WithoutExercise WithoutExercise andExercise andExercise
Characteristic (n=102) (n=102) (n=103) (n=102)
Age,y 73.8(3.1) 74.1(3.0) 74.8(2.9) 74.1(2.9)
Height,cm 160.7(5.4) 159.2(5.8) 159.4(6.1) 159.7(5.9)
Weight,kg 72.0(12.4) 73.0(13.1) 70.9(10.6) 73.2(10.5)
Fat,% 41.1(6.7) 42.0(7.2) 41.3(6.4) 42.8(5.3)
Calciumintake,mg/d 1040(345) 1125(420) 1119(346) 1109(385)
VitaminDintake,μg/d 10.2(4.1) 10.9(4.2) 10.3(3.6) 10.4(3.9)
Serum25-hydroxyvitaminDlevel, 27.1(7.5) 26.4(6.9) 27.8(7.2) 26.2(7.0)
ng/mL
Serumparathyroidhormonelevel, 5.0(2.7) 5.0(2.2) 4.7(2.0) 5.2(2)
pg/mL
Fastingserumcalciumlevel,mg/dL 9.40(0.76) 9.40(0.76) 9.36(0.76) 9.40(0.80)
Fastingserumphosphoruslevel,mg/dL 3.22(0.49) 3.31(0.46) 3.22(0.46) 3.19(0.49)
Dailystepsduringfirstmonth 6000(2636) 5812(2842) 5920(2458) 5831(2504)
Mini-MentalStateExaminationscore 28.5(1.7) 28.3(1.4) 28.2(1.4) 28.3(1.5)
(rangeof0-30)b
ShortPhysicalPerformanceBattery 10.6(3-12) 10.7(1-12) 10.9(7-12) 10.8(5-12)
score,mean(range)
ActivitiesofDailyLivingscore(rangeof 6.7(1.6) 7.0(2.2) 6.8(1.9) 6.9(1.8)
6-36)c
InstrumentalActivitiesofDailyLiving 9.8(2.7) 10.7(4.9) 9.9(3.8) 10.3(4.0)
score(rangeof8-48)c
Mobilitydifficultiesoutdoors,No.(%) 18(17.6) 19(18.6) 17(16.5) 17(16.7)
No.ofchildren 2.0(1.3) 2.0(1.2) 2.1(1.3) 2.1(1.2)
Ageatmenopause,y 50(5) 49(5) 49(5) 50(5)
Useofhormonetherapy,No.
Never 41 45 40 38
Ever 38 38 46 44
Current 23 19 17 20
SIconversionfactors:Toconvert
Medicalconditions,No.
serum25-hydroxyvitaminDlevelto
Hypertension 42 52 36 53 nanomolesperliter,multiplyby
Cardiovasculardisease 18 16 21 16 2.496;toconvertserumparathyroid
hormoneleveltonanogramsperliter,
Hypothyroidism 19 17 25 27
multiplyby1.0;toconvertfasting
Diabetesmellitus 9 12 10 6 serumcalciumleveltomillimolesper
Osteoarthritis 23 29 26 34 liter,multiplyby0.25;andtoconvert
fastingserumphosphoruslevelto
Depression 2 5 2 5
millimolesperliter,multiplyby0.323.
None 16 10 19 8 aValuesaremean(SD)unless
No.ofmedications 2.5(2.0) 2.6(1.9) 2.3(2.0) 2.7(1.9) otherwiseindicated.
Bloodpressure,mmHg bHigherscoreindicatesbetter
functioning.
Systolic 146(17) 148(18) 148(14) 148(17)
cLowerscoreindicatesbetter
Diastolic 81(9) 82(10) 82(9) 81(8)
functioning.
injuriousfalls.Coxproportionalhazardsregressionmodels
wereusedtocalculatehazardratiosforfallersandinjuredfall- Results
ersineachgroup,withtheplacebowithoutexercisegroupas
thereference. Therewerenoclinicallyrelevantbetween-groupdifferences
Forphysicalfunctioningandbonetraits,between-group inageoranthropometryatbaseline(Table1).Bodycomposi-
differencesintimewereestimatedbylinearmixedmodels tiondidnotchangesignificantlyduringthetrial.Themean(SD)
fornormallydistributedoutcomesandbygeneralizedlinear dailydietarycalciumintakewassufficientat1098(378)mgat
mixedmodelswithgammadistributionandloglinkfunc- baselineand1212(400)mgat24months.Themean(SD)daily
tion for nonnormally distributed outcomes using age, dietaryvitaminDintakewas10.4(3.9)μgatbaselineand10.5
height,weight,andtheuseofhormonetherapyascovari- (4.3)μgattheendoftheintervention.Alcoholconsumption
ates.Thesemethodsallowedtheincorporationofincom- waslow,and13womenwerecurrentsmokers.Fifty-three
pletelongitudinaldataintotheanalysis.Allstatisticalanaly- women(13.0%)weretakingnomedication,while87.0%had
seswereconductedusingasoftwareprogram(SPSS,version atleast1diagnosedchronicdisease,mostcommonlycardio-
22;IBM). vascular.
E4 JAMAInternalMedicine PublishedonlineMarch23,2015 (Reprinted) jamainternalmedicine.com
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
ExerciseandVitaminDinFallPrevention OriginalInvestigation Research
Table2.RateofFallsper100Person-yearsinEachStudyGroupDuringthe24-MonthInterventionandIRR
forFallsandInjuriousFalls
PlaceboWithout VitaminDWithout Placeboand VitaminDand
Outcome Exercise Exercise Exercise Exercise
Allfalls 118.2 132.1 120.7 113.1
Injuriousfalls 13.2 12.9 6.5 5.0
IRR(95%CI)
Allfalls 1[Reference] 1.08(0.78-1.52) 1.07(0.77-1.45) 0.99(0.72-1.39)
Injuriousfalls 1[Reference] 0.84(0.45-1.57) 0.46(0.22-0.95) 0.38(0.17-0.81)
Allmultiplefalls 1[Reference] 1.05(0.60-1.86) 1.11(0.63-1.94) 1.14(0.65-1.99)
Abbreviation:IRR,incidencerate
Multipleinjuriousfalls 1[Reference] 1.04(0.56-1.96) 1.10(0.59-2.05) 1.54(0.84-2.81)
ratio.
Thirty-ninewomen(9.5%)didnotcompletetheendpoint outexercisegroupanddifferedsignificantlyfromthatinall
measurements,withmostcitinghealthreasons,and4women otherstudygroups(Table3).LumbarspineBMDdidnotchange
died(Figure1).Themeanpillcompliancewas98.1%(range, significantlyinanygroup.VitaminDincreasedtrabecularbone
42.6%-100%),whilethemeanexercisecompliance(mea- densityatthetibiaslightlybutsignificantlybetweenthevi-
suredasattendanceatallofferedtrainingsessionsforgroup taminDandexercisegroupandtheplacebowithoutexercise
andhometraining)was72.8%(range,0%-97.4%)and66.1% group(P=.02).
(0%-100%),respectively.Themeanintensityofsupervised Themean(SD)numberofdailystepswas5930(2512)over
trainingrangedfrom1.6METs(stretchingorresting)to5.6 theentirestudyperiod,withnobetween-groupdifferences.
METs.Individualmaximalvaluesweremorethan7METs. Individualdailystepsrangedfrom1200to16500.
Ingeneral,thetrainingprogramwaswelltolerated.There ChangesinphysicalfunctioningaresummarizedinTable3
werenosevereadverseeffectsorinjuriesduetothetraining. andeFigure2inSupplement2.Normalwalkingspeedwas
Twenty-twoparticipantsfromtheexercisegroupsand1par- maintainedintheplaceboandexercisegroupcomparedwith
ticipantfromthenonexercisegroupsconsultedtheattend- theplacebowithoutexercisegroup(P=.007),whiledeclin-
ingphysician(P.K.)becauseofmusculoskeletalcomplaints, ingsimilarlyinothergroups.Chairstandtimeimprovedinboth
mainlymildoverusesymptoms(eTableinSupplement2).In exercisegroups,showingmorethan6%improvementcom-
addition,3injuriesoccurredduringthegymtraining.Three paredwiththeplacebowithoutexercisegroupbutreaching
exerciserswithdrewfromtrainingduringthefirstweeksofthe statisticalsignificanceonlyintheplaceboandexercisegroup
programbecauseofpreexistingosteoarthriticsymptoms. (P=.03).TheTUGtimedeterioratedsignificantlymoreinthe
VitaminDlevelsdifferedsignificantlybetweenthevita- vitaminDwithoutexercisegroupcomparedwiththeplacebo
minDandplacebogroups.Themean(SD)serum25(OH)Dlev- withoutexercisegroup(P=.01).Othergroupsdidnotdiffer
elsremainedstableintheplacebogroupsat27.5(7.4)ng/mL fromtheplacebowithoutexercisegroup.Backwardwalking
atbaselineand27.5(6.9)ng/mLat24months,withsmallsea- improvedsignificantlyamongexercisers.Thedifferencecom-
sonalvariation,whilethemean(SD)levelsincreasedinthevi- paredwiththeplacebowithoutexercisegroupwasstatisti-
taminDgroupsfrom25.1(6.9)ng/mLatbaselineto37.0(7.4) callysignificantintheplaceboandexercisegroup(P=.001)
ng/mLat24months(eFigure1inSupplement2)(toconvert andinthevitaminDandexercisegroup(P=.03).Irrespec-
serum25[OH]Dleveltonanomolesperliter,multiplyby2.496). tiveofvitaminD,exerciseincreasedmusclestrength,while
Smallseasonalvariationswereobservedinserumintactpara- vitaminDalonehadnoeffect.Thepredictedmeanincrease
thyroidhormoneintheplacebogroups,whilethatinthevi- inlowerlimbextensionstrengthwasalmost15%inbothex-
taminDgroupsdeclinedslightlyfrombaseline,remaining ercisegroupsanddifferedsignificantlyfromtheplacebowith-
stablethereafter. outexercisegroup(P<.001).
NointeractionwasfoundbetweenvitaminDandexer-
cise.Intotal,therewere928fallsand281fallers,withnobe-
tween-groupdifferences(therateoffallsissummarizedin
Discussion
Table2).However,hazardratiosforinjuredfallerswerelower
inbothexercisegroupscomparedwiththeplacebowithout ThislargerandomizedclinicaltrialofvitaminDandexer-
exercisegroup.Hazardratioswere0.47(95%CI,0.23-0.99)for ciseshowedthatexercisetrainingreducedinjuriousfalls
theplaceboandexercisegroupand0.38(95%CI,0.17-0.83)for amonghome-dwellingolderwomen,whiletherateoffalls
thevitaminDandexercisegroup.ThevitaminDwithoutex- wasnotaffectedbyeithertreatment.Exerciseimproved
ercisegroupdidnotdifferfromtheplacebowithoutexercise physicalfunctioningbutvitaminDdidnot(contrarytoini-
group(Figure2).Resultsweresimilarfortheincidenceratera- tialexpectations).However,vitaminDreducedbonelossat
tiosofinjuriousfalls(Table2).Thenumbersofmultiplefall- thefemoralneckandincreasedtrabeculardensityatthe
ers(n=190)andmultipleinjuredfallers(n=117)weredistrib- distaltibia.
utedsimilarlyacrossthegroups. CurrentevidencefortheeffectivenessofvitaminDinfall
Duringtheintervention,femoralneckBMDdeclinedinall preventionisinconsistent,mostlikelybecauseofvaryingstudy
groups,butthemeandeclinewasgreatestintheplacebowith- designsandbaseline25(OH)Dlevelsaswellasdifferentdos-
jamainternalmedicine.com (Reprinted) JAMAInternalMedicine PublishedonlineMarch23,2015 E5
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
Figure2.HazardRatios(95%CIs)forFallers,InjuredFallers,andMultipleFallersUsingthePlacebo
WithoutExerciseGroupastheReference
0.05
0.04
0.03
0.02
0.01
0
0 5 10 15 20 25
agesortypesofvitaminDsupplementsused.Accordingto creasedthenumberofinjuredfallers.Apparently,thiseffect
someexperts,anadequateserum25(OH)Dlevelshouldbeat wasattributabletoimprovedphysicalfunctioning.Muscle
least30ng/mL,20,21whilemanyguidelinesconsider20ng/mL strengthandbalancetraininghasbeenshowntopreventfalls
tobesufficient.22Weaimedtorecruitparticipantsfromthegen- in community-dwelling older adults, and recent meta-
eralpopulationregardlessofvitaminDstatus,andserum25 analyseshaveconfirmedthatsuchexerciseprogramsareef-
(OH)Dlevelsweremeasuredonlyafterrandomization. fectiveinpreventingfall-inducedinjuries.3,27
Thereisalsoinconclusiveevidenceonwhethervitamin Exerciseimprovedmusclestrength,balance,andmobil-
Dcouldmodulatephysicalfunctioning.4,8Inapopulation- ityexceptfortheTUGtime.Surprisingly,vitaminDseemed
basedsurveyofmenandwomen60yearsorolder,ahigher toworsentheTUGtime.Similarly,althoughnormalwalking
25(OH)Dlevelwasassociatedwithbetterneuromuscular speedwasmaintainedinbothexercisegroupswithorwith-
function.7Surprisingly,chairstandtestperformanceap- outvitaminD,thevitaminDwithoutexercisegroupshowed
pearedtodeclineatthehighest25(OH)Dlevelsexceeding120 thegreatestdecline.Anotherunexpectedfindingwasthatex-
nmol/L(>48ng/mL),7possiblybecauseoffewobservationsin erciserstreatedwithvitaminDsupplementationshowedcon-
thehighestcategory.Thisfindingneedsconfirmation.Intrials sistentlysmallerbenefitsthanexercisersreceivingplacebo.
usinghighdosagesofvitaminD,high25(OH)Dlevelshavein- Therefore,ourresultsindicatethatvitaminDmaynotim-
creasedtheriskoffallsandfractures,suggestingnegativein- proveneuromuscularfunction,atleastwhenvitaminDin-
fluencesonbalanceandmobility.23,24Littleisknownaboutthe takeissufficient.
combinedeffectsofvitaminDandexercise.Resultsof2pilot Despiteimprovedphysicalperformance,exercisecon-
studies25,26havesuggestedapositiveinfluence.Infrailel- ferrednoeffectontheoverallfallrate.Recentstudies28,29have
derlypatientswithacutehipfracture,Bischoff-Ferrarietal9 providedsimilarresults.Morefallshavebeenreportedamong
reportedthatvitaminDtreatmentreducedhospitalreadmis- exercisersdespiteimprovedmusclestrengthandphysical
sionbutnotfalls,whereasphysiotherapywassuccessfulinre- performance.28Nevertheless,inourstudy,therateofinjuri-
ducingfallsbutnothospitalreadmission.Aneffectonfallswas ousfallsandinjuredfallersmorethanhalvedamongexercis-
foundinthephysicaltherapygroup,althoughgainsinphysi- ers.Goodphysicalconditionmayhelppreventinjuriesdur-
calfunctioningwerefoundonlyamongparticipantsadher- ingafall,perhapsviabetterandsaferlandingtechniques.This
enttothephysiotherapyhomeprogram. trendfullyconcurswithrecentmeta-analyses.3,27
Inthepresenttrial,exercisetraining(irrespectiveofvita- Exercisetrainingwasprimarilyintendedtoimprovebal-
minDsupplementation)reducedinjuriousfallsandde- ance,musclestrength,andmobilityratherthanbonedensity
Copyright 2015 American Medical Association. All rights reserved.
drazaH
evitalumuC
Research OriginalInvestigation ExerciseandVitaminDinFallPrevention
Injured fallers
Placebo without exercise
Vitamin D without exercise
Placebo and exercise
Vitamin D and exercise
Time, mo
Vitamin D Placebo Vitamin D
Without Exercise and Exercise and Exercise
Cumulativehazardispresentedfor
Fallers 0.77 (0.54-1.11) 0.93 (0.66-1.31) 0.91 (0.64-1.28)
Injured fallers 0.89 (0.47-1.69) 0.47 (0.23-0.99)a 0.38 (0.17-0.83)a theinjuredfallers.
Multiple fallers 1.07 (0.71-1.62) 1.14 (0.76-1.71) 1.14 (0.77-1.71) aP<.05comparedwiththeplacebo
withoutexercisegroup.
E6 JAMAInternalMedicine PublishedonlineMarch23,2015 (Reprinted) jamainternalmedicine.com
Copyright 2015 American Medical Association. All rights reserved.
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
ExerciseandVitaminDinFallPrevention OriginalInvestigation Research
Table3.BaselineValuesinBoneTraitsandPhysicalFunctioninginEachStudyGroup
Mean(95%CI),%
Outcome AbsoluteValue,Mean(SD) Changeat12mo Changeat24mo PValuea
FemoralNeckBMD,g/cm2
Placebowithoutexercise 0.87(0.14) −1.25(−4.78to2.41) −1.22(−4.75to2.45) NA
VitaminDwithoutexercise 0.82(0.11) −0.30(−3.92to3.46) −0.87(−4.47to2.86) .02
Placeboandexercise 0.85(0.12) −0.32(−3.90to3.39) −0.98(−4.55to2.73) .01
VitaminDandexercise 0.88(0.13) −0.51(−4.03to3.14) −1.24(−4.72to2.38) .04
LumbarSpineBMD,g/cm2
Placebowithoutexercise 1.15(0.23) 0.62(−3.66to4.90) 1.21(−3.09to5.51) NA
VitaminDwithoutexercise 1.12(0.20) 0.60(−3.83to5.03) 1.29(−3.16to5.75) .33
Placeboandexercise 1.13(0.21) 0.12(−4.24to4.48) 0.48(−3.91to4.87) .32
VitaminDandexercise 1.17(0.22) 0.33(−3.87to4.53) 0.77(−3.43to4.97) .77
DistalTibiaTrabecularDensity,mg/cm3
Placebowithoutexercise 220.3(34.8) −0.25(−3.54to3.03) −0.49(−3.77to2.80) NA
VitaminDwithoutexercise 217.9(28.6) −0.09(−3.50to3.32) 0.03(−3.36to3.42) .12
Placeboandexercise 224.5(29.4) −0.13(−3.39to3.13) −0.16(−3.43to3.11) .41
VitaminDandexercise 224.4(31.4) 0.17(−3.05to3.39) 0.19(−3.04to3.42) .02
TibialShaftCorticalDensity,mg/cm3
Placebowithoutexercise 1104.6(37.0) −0.07(−0.78to0.64) −0.13(−0.85to0.58) NA
VitaminDwithoutexercise 1106.3(38.0) 0.05(−0.65to0.75) 0.11(−0.60to0.82) .08
Placeboandexercise 1106.5(33.6) −0.04(−0.72to0.65) −0.08(−0.77to0.62) .68
VitaminDandexercise 1114.4(34.0) −0.06(−0.75to0.63) −0.12(−0.82to0.58) .93
TibialShaftCorticalArea,mm2
Placebowithoutexercise 277.7(40.5) −0.12(−3.29to3.05) −0.24(−3.44to2.95) NA
VitaminDwithoutexercise 273.5(39.7) −0.31(−3.62to3.01) −0.86(−4.20to2.49) .55
Placeboandexercise 277.5(36.6) −0.36(−3.60to2.88) −1.16(−4.42to2.10) .33
VitaminDandexercise 271.9(31.3) −0.70(−3.89to2.50) −1.27(−4.44to1.91) .64
TibialShaftStrengthStrainIndex,mm3
Placebowithoutexercise 1749.3(270.7) 0.22(−3.34to3.79) 0.25(−3.34to3.84) NA
VitaminDwithoutexercise 1696.5(283.7) 0.06(−3.71to3.84) −0.31(−4.13to3.50) .25
Placeboandexercise 1716.6(277.0) −0.17(−3.80to3.46) −1.16(−4.82to2.50) .21
VitaminDandexercise 1719.0(248.7) −0.74(−4.32to2.85) −1.26(−4.83to2.31) .40
RatioofCorticaltoTotalArea
Placebowithoutexercise 0.17(0.05) −1.44(−9.16to6.28) −2.00(−9.76to5.77) NA
VitaminDwithoutexercise 0.16(0.05) −0.65(−8.58to7.29) −1.12(−9.13to6.89) .48
Placeboandexercise 0.17(0.05) −0.78(−8.49to6.93) −0.07(−7.83to7.70) .17
VitaminDandexercise 0.18(0.06) −0.77(−7.98to6.44) −1.66(−8.83to5.50) .98
NormalWalkingSpeed,m/s
Placebowithoutexercise 1.04(0.21) −1.64(−5.65to2.36) −2.51(−6.72to1.69) NA
VitaminDwithoutexercise 1.00(0.21) −2.73(−7.03to1.58) −3.30(−7.82to1.22) .72
Placeboandexercise 1.01(0.19) 4.21(0.05to8.36) −0.10(−4.51to4.30) .007
VitaminDandexercise 1.03(0.20) 0.03(−3.98to4.03) −1.80(−6.00to2.41) .46
ChairStandTime,s
Placebowithoutexercise 12.6(2.4) −0.76(−5.07to3.76) −1.30(−6.02to3.65) NA
VitaminDwithoutexercise 12.6(3.3) −1.57(−5.97to3.04) −3.49(−8.25to1.52) .46
Placeboandexercise 12.5(2.8) −4.30(−8.39to−0.06) −7.80(−12.20to−3.20) .03
VitaminDandexercise 12.4(2.5) −3.63(−7.70to0.63) −6.95(−11.30to−2.40) .05
TimedUpandGoTime,s
Placebowithoutexercise 9.3(2.1) −0.79(−5.36to4.01) −1.93(−6.70to3.09) NA
VitaminDwithoutexercise 9.7(6.4) 2.25(−2.68to7.44) 4.20(−1.10to9.79) .01
Placeboandexercise 8.9(1.9) −0.19(−5.46to5.37) 0.35(−5.26to6.28) .19
VitaminDandexercise 8.9(1.6) −0.99(−6.05to4.36) −1.75(−7.11to3.93) .63
(continued)
jamainternalmedicine.com (Reprinted) JAMAInternalMedicine PublishedonlineMarch23,2015 E7
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
Research OriginalInvestigation ExerciseandVitaminDinFallPrevention
Table3.BaselineValuesinBoneTraitsandPhysicalFunctioninginEachStudyGroup(continued)
Mean(95%CI),%
Outcome AbsoluteValue,Mean(SD) Changeat12mo Changeat24mo PValuea
BackwardWalking,ProportionofThose
AbletoDo6.1min,%
Placebowithoutexercise 41.8 4.41(−5.19to14.42) 7.76(−2.87to18.47) NA
VitaminDwithoutexercise 30.3 2.91(−5.89to12.87) 9.48(−0.66to20.08) .68
Placeboandexercise 45.8 30.92(21.87to38.09) 26.27(15.71to35.13) .001
VitaminDandexercise 51.0 24.57(15.63to31.98) 25.47(15.30to33.39) .03
MuscleStrength,N/kg
Placebowithoutexercise 23.1(6.1) 2.8(−3.4to9.0) 1.8(−4.8to8.4) NA
VitaminDwithoutexercise 23.4(7.7) −0.9(−7.1to5.4) 1.5(−5.0to8.1) .10
Placeboandexercise 23.6(6.0) 17.3(11.4to23.2) 14.0(7.8to20.2) <.001
VitaminDandexercise 22.2(6.6) 18.0(11.7to24.1) 15.6(9.1to22.2) <.001
Abbreviations:BMD,bonemineraldensity;NA,notapplicable.
aComparedwiththeplacebowithoutexercisegroup.
becauselimitedphysicalcapacityorcomorbiditiesofpartici- eficialeffectsofthevitamin.ItispossiblethatvitaminDhas
pantswerelikelytorestricttheintensityortypeofloading greatereffectsonfallriskamongwomenwithvitaminD
neededtostrengthenbone.Nevertheless,bothvitaminD depletion.9,10,31Ontheotherhand,allparticipantshadfallen
groupsshowedincreasedtrabecularbonedensityinthetibia, previouslyandthuswereatincreasedriskoffalling,andvi-
suggestingthatthemean25(OH)Dlevelsweresufficientfora taminDsupplementationisnowrecommendedasameansto
skeletaleffect(84.6%ofparticipantsinbothvitaminDgroups reducetheriskoffallsirrespectiveofbaselinevitaminDlev-
exceededthetargetlevelof≥30ng/mL).20Althoughvitamin els.Althoughtheexerciseprogramwasplannedtobesuit-
Dandexercise(aloneorincombination)couldnotincrease ableandsafeforwomenwithmusculoskeletalproblems,itwas
femoralneckBMD,bothtreatmentsreducedbonelossatthis challengingtoreachandrecruitthefrailestwomen.Inother
clinicallyrelevantbonesite. words,ourparticipantswereingoodhealthandphysicalcon-
Thisstudyhasseveralstrengths.Toourknowledge,itis dition.Therefore,ourresultscannotbegeneralizedtofrailand
thefirstlargerandomizedclinicaltrialwithalong(2-year)du- institutionalizedwomenortomen.
rationthatwasdouble-blindedtovitaminDstatus,evaluat-
ingtheeffectivenessofvitaminDandexercisetraininginpre-
ventingfallsandrelatedinjuriesinolderwomen.Second,
Conclusions
withdrawalfromthestudywaslowatonly9.5%.Third,pill
compliancewasexcellent,andparticipationinexercisetrain- Giventhefactthatfallriskismultifactorial,exercisemaybe
ingwasgood.Fourth,fallswereassessedmonthlyusingfall themosteffectiveandfeasiblestrategyforpreventinginjuri-
diaries,andallreportedfallswerescrutinizedbytheinvesti- ousfallsincommunity-dwellingolderadultsrepletewith
gators.Fifth,physicalfunctioningandbonetraitswerecom- vitaminD.Herein,vitaminDincreasedbonedensityslightly,
prehensivelyassessed.Furthermore,whenplanningourtrial, andexerciseimprovedphysicalfunctioning.Whileneither
therewasnoconsensusonthedefinitionofinjuriousfalls.In treatmentreducedtherateoffalling,injuriousfallsmore
2012,Schwenketal30proposedaclassification,andourdefi- thanhalvedamongexerciserswithorwithoutvitaminD.
nitionconformswiththisrecommendation. OurparticipantswerevitaminDreplete,withsufficientcal-
Therewerealsolimitationstoourstudy.Becauseofthe ciumintake.Futureresearchisneededtoelaboratetherole
fortificationoffluidmilkproductsinFinland,thebaseline25 ofvitaminDtoenhancephysicalfunctioninginelderly
(OH)Dlevelswerelikelytoohightorevealallpotentialben- women.
ARTICLEINFORMATION Criticalrevisionofthemanuscriptforimportant collection,management,analysis,and
AcceptedforPublication:December14,2014. intellectualcontent:Allauthors. interpretationofthedata;preparation,review,or
Statisticalanalysis:Uusi-Rasi,Patil,Tokola. approvalofthemanuscript;anddecisiontosubmit
PublishedOnline:March23,2015. Administrative,technical,ormaterialsupport:All themanuscriptforpublication.
doi:10.1001/jamainternmed.2015.0225. authors.
AuthorContributions:DrUusi-Rasihadfullaccess Studysupervision:Uusi-Rasi. REFERENCES
toallthedatainthestudyandtakesresponsibility ConflictofInterestDisclosures:Nonereported. 1.TinettiME.Clinicalpractice:preventingfallsin
f do ar tath ae ni an lt ye sg isr .ityofthedataandtheaccuracyofthe Funding/Support:Thisstudywassupportedbythe elderlypersons.NEnglJMed.2003;348(1):42-49.
Studyconceptanddesign:Uusi-Rasi,Kannus, AcademyofFinland,MinistryofEducationand 2.CarterND,KannusP,KhanKM.Exerciseinthe
Karinkanta,Sievänen,Lamberg-Allardt. Culture,CompetitiveResearchFundofPirkanmaa preventionoffallsinolderpeople:asystematic
Acquisition,analysis,orinterpretationofdata: HospitalDistrict,andJuhoVainioFoundation. literaturereviewexaminingtherationaleandthe
Uusi-Rasi,Patil,Karinkanta,Kannus,Tokola. RoleoftheFunder/Sponsor:Thefundingsources evidence.SportsMed.2001;31(6):427-438.
Draftingofthemanuscript:Uusi-Rasi,Patil,Kannus. hadnoroleinthedesignandconductofthestudy;
E8 JAMAInternalMedicine PublishedonlineMarch23,2015 (Reprinted) jamainternalmedicine.com
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
ExerciseandVitaminDinFallPrevention OriginalInvestigation Research
3.KemmlerW,HäberleL,vonStengelS.Effectsof PreventionofFallsNetworkEuropeconsensus. falls,mobility,andmusclestrengthinolder
exerciseonfracturereductioninolderadults: JAmGeriatrSoc.2005;53(9):1618-1622. postmenopausalwomen:arandomizedcontrolled
asystematicreviewandmeta-analysis.Osteoporos 14.OutilaTA,KärkkäinenMU,Lamberg-AllardtCJ. trial.JBoneMinerRes.2012;27(1):170-176.
Int.2013;24(7):1937-1950. VitaminDstatusaffectsserumparathyroid 24.SandersKM,StuartAL,WilliamsonEJ,etal.
4.GillespieLD,RobertsonMC,GillespieWJ,etal. hormoneconcentrationsduringwinterinfemale Annualhigh-doseoralvitaminDandfallsand
Interventionsforpreventingfallsinolderpeople adolescents:associationswithforearmbone fracturesinolderwomen:arandomizedcontrolled
livinginthecommunity.CochraneDatabaseSystRev. mineraldensity.AmJClinNutr.2001;74(2):206-210. trial.JAMA.2010;303(18):1815-1822.
2012;9:CD007146. 15.Uusi-RasiK,RauhioA,KannusP,etal. 25.SwanenburgJ,deBruinED,StauffacherM,
5.PalvanenM,KannusP,PiirtolaM,NiemiS, Three-monthweightreductiondoesnotcompromise MulderT,UebelhartD.Effectsofexerciseand
ParkkariJ,JärvinenM.EffectivenessoftheChaos bonestrengthinobesepremenopausalwomen.Bone. nutritiononposturalbalanceandriskoffallingin
FallsClinicinpreventingfallsandinjuriesof 2010;46(5):1286-1293. elderlypeoplewithdecreasedbonemineral
home-dwellingolderadults:arandomised 16.SievänenH,KoskueV,RauhioA,KannusP, density:randomizedcontrolledtrialpilotstudy.Clin
controlledtrial.Injury.2014;45(1):265-271. HeinonenA,VuoriI.Peripheralquantitative Rehabil.2007;21(6):523-534.
6.WichertsIS,vanSchoorNM,BoekeAJ,etal. computedtomographyinhumanlongbones: 26.BunoutD,BarreraG,LeivaL,etal.Effectsof
VitaminDstatuspredictsphysicalperformanceand evaluationofinvitroandinvivoprecision.JBone vitaminDsupplementationandexercisetrainingon
itsdeclineinolderpersons.JClinEndocrinolMetab. MinerRes.1998;13(5):871-882. physicalperformanceinChileanvitaminDdeficient
2007;92(6):2058-2065. 17.GuralnikJM,SimonsickEM,FerrucciL,etal. elderlysubjects.ExpGerontol.2006;41(8):746-752.
7.Bischoff-FerrariHA,DietrichT,OravEJ,etal. AShortPhysicalPerformanceBatteryassessing 27.El-KhouryF,CassouB,CharlesMA,
Higher25-hydroxyvitaminDconcentrationsare lowerextremityfunction:associationwith Dargent-MolinaP.Theeffectoffallprevention
associatedwithbetterlower-extremityfunctionin self-reporteddisabilityandpredictionofmortality exerciseprogrammesonfallinducedinjuriesin
bothactiveandinactivepersonsaged(cid:2)60y.AmJ andnursinghomeadmission.JGerontol.1994;49 communitydwellingolderadults:systematic
ClinNutr.2004;80(3):752-758. (2):M85-M94. reviewandmeta-analysisofrandomisedcontrolled
8.AnnweilerC,SchottAM,BerrutG,FantinoB, 18.PodsiadloD,RichardsonS.Thetimed“Up& trials.BMJ.2013;347:f6234.
BeauchetO.VitaminD–relatedchangesinphysical Go”:atestofbasicfunctionalmobilityforfrail 28.GianoudisJ,BaileyCA,EbelingPR,etal.Effects
performance:asystematicreview.JNutrHealth elderlypersons.JAmGeriatrSoc.1991;39(2):142-148. ofatargetedmultimodalexerciseprogram
Aging.2009;13(10):893-898. 19.HusuP,SuniJ,PasanenM,MiilunpaloS. incorporatinghigh-speedpowertrainingonfalls
9.Bischoff-FerrariHA,Dawson-HughesB,PlatzA, Health-relatedfitnesstestsaspredictorsof andfractureriskfactorsinolderadults:
etal.Effectofhigh-dosagecholecalciferoland difficultiesinlong-distancewalkingamong acommunity-basedrandomizedcontrolledtrial.
extendedphysiotherapyoncomplicationsafterhip high-functioningolderadults.AgingClinExpRes. JBoneMinerRes.2014;29(1):182-191.
fracture:arandomizedcontrolledtrial.ArchIntern 2007;19(6):444-450. 29.FreibergerE,HäberleL,SpirdusoWW,Zijlstra
Med.2010;170(9):813-820. 20.Dawson-HughesB,HeaneyRP,HolickMF,Lips GA.Long-termeffectsofthreemulticomponent
10.MuirSW,Montero-OdassoM.Effectofvitamin P,MeunierPJ,ViethR.Estimatesofoptimalvitamin exerciseinterventionsonphysicalperformanceand
Dsupplementationonmusclestrength,gaitand Dstatus.OsteoporosInt.2005;16(7):713-716. fall-relatedpsychologicaloutcomesin
b ma ela tan -c ae ni an lyo sl id se .Jra Ad mul Gts e: ra ias ty rs St oe cm .2a 0tic 11r ;e 5v 9i (e 1w 2):a 2n 2d 91- 2 E1 n. dH oco rl ii nck eM SoF c, iB etin y.k Ele vy alN uC at, iB oi ns ,c th ro ef af t- mFe er nra tr ,i aH nA d,etal; c coo nm tm rou llen dity tr- id aw l.Jel Alin mg Go eld rie ar tra Sd ou clt .s 2: 0a 1r 2a ;n 6d 0o (m 3)i :z 4e 3d 7-446.
2300. preventionofvitaminDdeficiency:anEndocrine 30.SchwenkM,LauenrothA,StockC,etal.
11.RobertsonMC,GillespieLD.Fallpreventionin Societyclinicalpracticeguideline[published Definitionsandmethodsofmeasuringand
community-dwellingolderadults.JAMA.2013;309 correctionappearsinJClinEndocrinolMetab. reportingoninjuriousfallsinrandomisedcontrolled
(13):1406-1407. 2011;96(12):3908].JClinEndocrinolMetab.2011; fallpreventiontrials:asystematicreview.BMCMed
12.Uusi-RasiK,KannusP,KarinkantaS,etal.Study 96(7):1911-1930. ResMethodol.2012;12:50.
protocolforpreventionoffalls:arandomized 22.Lamberg-AllardtC,BrustadM,MeyerHE, 31.ZhuK,AustinN,DevineA,BruceD,PrinceRL.A
controlledtrialofeffectsofvitaminDandexercise SteingrimsdottirL.VitaminD:asystematicliterature randomizedcontrolledtrialoftheeffectsofvitamin
onfallsprevention.BMCGeriatr.2012;12:12. reviewforthe5theditionoftheNordicNutrition Donmusclestrengthandmobilityinolderwomen
13.LambSE,Jørstad-SteinEC,HauerK,BeckerC; Recommendations.FoodNutrRes.2013;57. w 58it (h 11v ):i 2ta 0m 6i 3n -2D 0in 6s 8u .fficiency.JAmGeriatrSoc.2010;
PreventionofFallsNetworkEuropeandOutcomes 23.GlendenningP,ZhuK,InderjeethC,HowatP,
ConsensusGroup.Developmentofacommon LewisJR,PrinceRL.Effectsofthree-monthlyoral
outcomedatasetforfallinjurypreventiontrials:the 150,000IUcholecalciferolsupplementationon
jamainternalmedicine.com (Reprinted) JAMAInternalMedicine PublishedonlineMarch23,2015 E9
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Seton Hall University User on 03/28/2015
